NCT02695654

Brief Summary

Adductor canal block has become popular as effective mean for pain relief following knee surgery.This block has not been checked in chronic pain patients.The purpose of this study is to assess the efficacy and safety of adductor canal block on chronic knee pain in patients with knee osteoarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

November 8, 2016

Status Verified

November 1, 2016

Enrollment Period

9 months

First QC Date

February 21, 2016

Last Update Submit

November 5, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Maximal and minimal Pain on the 11-point Numeric rating score Pain Scale (NRS -11)

    Numeric 11-point rating score is widely accepted self-reported score for measurement of chronic and acute pain in researches.Possible scores range are between 0-free of pain and 10-the worst imaginable pain

    Baseline ,1 hour,1 week and 4 weeks

Secondary Outcomes (4)

  • The Knee injury and osteoarthritis outcome(KOOS) score change in percentage from baseline and 1 month following adductor canal block

    Baseline and 1 month following adductor canal block

  • Maximum voluntary isometric contraction of quadriceps muscle (MVIC)

    prior, 1 hour ,1 week and 1 month after block measured by handheld dynamometer

  • Timed up to go test(TUG)

    prior, 1 hour ,1 week and 1 month after block

  • Satisfaction of patient

    1 month after block

Study Arms (1)

Chronic pain in knee osteoarthritis

Ultrasound guided single shot Adductor canal block with 0,25% Levobupivacaine 14 ml and 100 mcg Clonidine

Drug: LevobupivacaineDrug: Clonidine

Interventions

14 ml of 0,25 % Levobupivacaine

Also known as: Chirocaine
Chronic pain in knee osteoarthritis

Clonidine 100 mcg

Also known as: Catapresan
Chronic pain in knee osteoarthritis

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients included in our study were sent by family physicians to our Pain ambulance and all have alredy diagnosed knee osteoarthritis chronic pain.Diagnosis was confirmed(or not) from Ortopedist engaged in our study.Estimation of appropriatness was made by anesthesiologyst.

You may qualify if:

  • Outpatients Had pain in knee at least 6 months before the study Knee osteoarthritis chronic pain was diagnosed based on medical history, knee X- ray and orthopedic examination.
  • A sufficient level of education to understand study procedures and be able to communicate with site personnel

You may not qualify if:

  • Any cardiovascular, hepatic, or renal conditions that would compromise participation, in the opinion of the investigator
  • Severe neurologic conditions interfere with knee condition
  • Narcotic dependent (opioid intake more than 3 months and more than 30 mg of daily oral morphine equivalents)
  • Coexisting severe hematological disorder or with deranged coagulation parameters
  • Psychiatric illnesses
  • Allergy to any of the drugs used in the study
  • Infection or malignancy at the site of block
  • Any active systemic infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre

Ljubljana, 1000, Slovenia

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

LevobupivacaineClonidine

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

BupivacaineAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesImidazolinesImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Mensur Salihovic

    University Medical Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 21, 2016

First Posted

March 1, 2016

Study Start

November 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

November 8, 2016

Record last verified: 2016-11

Locations